{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:47:18Z","timestamp":1791341238554,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T00:00:00Z","timestamp":1351036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11899-012-0139-9","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T06:20:04Z","timestamp":1350973204000},"page":"267-275","source":"Crossref","is-referenced-by-count":15,"title":["\u201cAntivirals\u201d in the Treatment of Adult T Cell Leukaemia\u2013 Lymphoma (ATLL)"],"prefix":"10.1007","volume":"7","author":[{"given":"Paul A.","family":"Fields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,24]]},"reference":[{"issue":"10","key":"139_CR1","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1073\/pnas.77.10.6134","volume":"77","author":"JW Mier","year":"1980","unstructured":"Mier JW, Gallo RC. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA. 1980;77(10):6134\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"139_CR2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"139_CR3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79(6):2031\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"139_CR4","volume-title":"Human immunodeficiency viruses and human T cell lymphotropic viruses","author":"IARC Monographs on the Evaluation of Carcinogenic Risk to Humans","year":"1996","unstructured":"IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Human immunodeficiency viruses and human T cell lymphotropic viruses. Lyon: IARC; 1996."},{"issue":"2","key":"139_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.2910430214","volume":"43","author":"EL Murphy","year":"1989","unstructured":"Murphy EL, et al. Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43(2):250\u20133.","journal-title":"Int J Cancer"},{"issue":"11","key":"139_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","volume":"5","author":"A Bazarbachi","year":"2004","unstructured":"Bazarbachi A, et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol. 2004;5(11):664\u201372.","journal-title":"Lancet Oncol"},{"issue":"6","key":"139_CR7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ijc.2910430618","volume":"43","author":"T Kondo","year":"1989","unstructured":"Kondo T, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989;43(6):1061\u20134.","journal-title":"Int J Cancer"},{"issue":"3","key":"139_CR8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"\u2022 Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991;79(3):428\u201337. Original description of ATLL into disease subtypes.","journal-title":"Br J Haematol"},{"issue":"5","key":"139_CR9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1346-8138.2008.00465.x","volume":"35","author":"M Amano","year":"2008","unstructured":"Amano M, et al. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia\/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types. J Dermatol. 2008;35(5):270\u20135.","journal-title":"J Dermatol"},{"issue":"9","key":"139_CR10","first-page":"837","volume":"53","author":"A Okayama","year":"2005","unstructured":"Okayama A. Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection. Rinsho Byori. 2005;53(9):837\u201344.","journal-title":"Rinsho Byori"},{"issue":"8","key":"139_CR11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116(8):1211\u20139.","journal-title":"Blood"},{"key":"139_CR12","doi-asserted-by":"crossref","unstructured":"Hodson et al. Pre Morbid Human T Lymphotropic virus type I proviral load, rather than percentage of abnormal lymphmocytes, is associated with an increased risk of Agressive T cell Leukamia\/Lymphoma. In press Haematolgica; 2012.","DOI":"10.3324\/haematol.2012.069476"},{"issue":"4","key":"139_CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270\u201380.","journal-title":"Nat Rev Cancer"},{"key":"139_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-4-27","volume":"4","author":"PV Afonso","year":"2007","unstructured":"Afonso PV, et al. Centrosome and retroviruses: the dangerous liaisons. Retrovirology. 2007;4:27.","journal-title":"Retrovirology"},{"issue":"4","key":"139_CR15","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.166.4.2602","volume":"166","author":"JM Mariner","year":"2001","unstructured":"Mariner JM, et al. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol. 2001;166(4):2602\u20139.","journal-title":"J Immunol"},{"key":"139_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmicb.2012.00247","volume":"3","author":"T Zhao","year":"2012","unstructured":"\u2022 Zhao T, Matsuoka M. HBZ and its roles in HTLV-1 oncogenesis. Front Microbiol. 2012;3:247. Importance of HBZ in the pathogenesis of ATLL.","journal-title":"Front Microbiol"},{"issue":"3","key":"139_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1349-7006.1989.tb02289.x","volume":"80","author":"T Okamoto","year":"1989","unstructured":"Okamoto T, et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res. 1989;80(3):191\u20135.","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"139_CR18","first-page":"363","volume":"18","author":"K Moriyama","year":"1988","unstructured":"Moriyama K, et al. Immunodeficiency in preclinical smoldering adult T-cell leukemia. Jpn J Clin Oncol. 1988;18(4):363\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"43","key":"139_CR19","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1038\/sj.onc.1203870","volume":"19","author":"AS Gabet","year":"2000","unstructured":"Gabet AS, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19(43):4954\u201360.","journal-title":"Oncogene"},{"issue":"2","key":"139_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2011-05-357459","volume":"119","author":"K Sugata","year":"2012","unstructured":"Sugata K, et al. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood. 2012;119(2):434\u201344.","journal-title":"Blood"},{"issue":"39","key":"139_CR21","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene. 2005;24(39):6047\u201357.","journal-title":"Oncogene"},{"issue":"2","key":"139_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001;113(2):375\u201382.","journal-title":"Br J Haematol"},{"issue":"34","key":"139_CR23","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25(34):5458\u201364.","journal-title":"J Clin Oncol"},{"issue":"1","key":"139_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1073\/pnas.80.1.26","volume":"80","author":"JA Lewis","year":"1983","unstructured":"Lewis JA, Mengheri E, Esteban M. Induction of an antiviral response by interferon requires thymidine kinase. Proc Natl Acad Sci USA. 1983;80(1):26\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"139_CR25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-111-11-871","volume":"111","author":"D Shibata","year":"1989","unstructured":"\u2022 Shibata D, et al. Human T Cell lymphotropic virus type I (HTLV-1)-associated adult T Cell lymphoma in a patient infected with human immunodeficiency virus type \u22121(HIV-1). Ann Intern Med. 1989;111(11):871\u20135. First description of efficacy of AVT in ATLL.","journal-title":"Ann Intern Med"},{"key":"139_CR26","doi-asserted-by":"crossref","unstructured":"\u2022 Gill PS, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995;332(26):1744\u20138. First reports of efficacy in AVT in ATLL patients.","DOI":"10.1056\/NEJM199506293322603"},{"issue":"26","key":"139_CR27","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"\u2022 Hermine O, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995;332(26):1749\u201351. First reports of efficacy in AVT in ATLL patients.","journal-title":"N Engl J Med"},{"issue":"3","key":"139_CR28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","volume":"113","author":"E Matutes","year":"2001","unstructured":"Matutes E, et al. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol. 2001;113(3):779\u201384.","journal-title":"Br J Haematol"},{"issue":"6","key":"139_CR29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, et al. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma. Hematol J. 2002;3(6):276\u201382.","journal-title":"Hematol J"},{"issue":"27","key":"139_CR30","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"\u2022 Bazarbachi A, et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28(27):4177\u201383. Worldwide analysis of large series of patients confirming of AVT in Leukaemic forms of ATLL.","journal-title":"J Clin Oncol"},{"issue":"35","key":"139_CR31","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","volume":"29","author":"A Hodson","year":"2011","unstructured":"\u2022 Hodson A, et al. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma. J Clin Oncol. 2011;29(35):4696\u2013701. Further large series of patients confirming benefit of AVT in ATLL.","journal-title":"J Clin Oncol"},{"issue":"5","key":"139_CR32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12185-010-0717-3","volume":"92","author":"K Ishitsuka","year":"2010","unstructured":"Ishitsuka K, et al. Interferon-alpha and zidovudine for relapsed\/refractory adult T cell leukemia\/lymphoma: case reports of Japanese patients. Int J Hematol. 2010;92(5):762\u20134.","journal-title":"Int J Hematol"},{"issue":"22","key":"139_CR33","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","volume":"115","author":"Y Takasaki","year":"2010","unstructured":"Takasaki Y, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. 2010;115(22):4337\u201343.","journal-title":"Blood"},{"issue":"Pt 10","key":"139_CR34","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol. 2000;81(Pt 10):2341\u201364.","journal-title":"J Gen Virol"},{"issue":"11","key":"139_CR35","doi-asserted-by":"crossref","first-page":"e1001177","DOI":"10.1371\/journal.ppat.1001177","volume":"6","author":"S Oliere","year":"2010","unstructured":"Oliere S, et al. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog. 2010;6(11):e1001177.","journal-title":"PLoS Pathog"},{"issue":"24","key":"139_CR36","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1128\/JVI.77.24.13389-13395.2003","volume":"77","author":"X Feng","year":"2003","unstructured":"Feng X, Heyden NV, Ratner L. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol. 2003;77(24):13389\u201395.","journal-title":"J Virol"},{"issue":"10","key":"139_CR37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0145-2126(90)90172-6","volume":"14","author":"T Isono","year":"1990","unstructured":"Isono T, Ogawa K, Seto A. Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits. Leuk Res. 1990;14(10):841\u20137.","journal-title":"Leuk Res"},{"issue":"12","key":"139_CR38","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1128\/JVI.73.12.10289-10295.1999","volume":"73","author":"GP Taylor","year":"1999","unstructured":"Taylor GP, et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol. 1999;73(12):10289\u201395.","journal-title":"J Virol"},{"issue":"5","key":"139_CR39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/v3050469","volume":"3","author":"B Macchi","year":"2011","unstructured":"Macchi B, et al. Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. Viruses. 2011;3(5):469\u201383.","journal-title":"Viruses"},{"issue":"19","key":"139_CR40","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","volume":"116","author":"PV Afonso","year":"2010","unstructured":"Afonso PV, et al. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood. 2010;116(19):3802\u20138.","journal-title":"Blood"},{"issue":"8","key":"139_CR41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.onc.1210718","volume":"27","author":"A Datta","year":"2008","unstructured":"Datta A, Nicot C. Telomere attrition induces a DNA double-strand break damage signal that reactivates TP53 transcription in HTLV-I leukemic cells. Oncogene. 2008;27(8):1135\u201341.","journal-title":"Oncogene"},{"issue":"3","key":"139_CR42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","volume":"108","author":"A Datta","year":"2006","unstructured":"\u2022 Datta A, et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to TP53-dependent senescence. Blood. 2006;108(3):1021\u20139. Mechanism of AZT in ATLL and requirement for wild type TP53 status.","journal-title":"Blood"},{"issue":"2","key":"139_CR43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2005.03.039","volume":"234","author":"M Tawara","year":"2006","unstructured":"Tawara M, et al. Impact of TP53 aberration on the progression of Adult T-cell Leukemia\/Lymphoma. Cancer Lett. 2006;234(2):249\u201355.","journal-title":"Cancer Lett"},{"issue":"7","key":"139_CR44","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","volume":"109","author":"JC Ramos","year":"2007","unstructured":"\u2022 Ramos JC, et al. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma. Blood. 2007;109(7):3060\u20138. Disease resistance to AVT by recogntion of overexpression of IRF-4.","journal-title":"Blood"},{"issue":"7","key":"139_CR45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3109\/10428191003728628","volume":"51","author":"AA Alizadeh","year":"2010","unstructured":"Alizadeh AA, et al. Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha. Leuk Lymphoma. 2010;51(7):1200\u201316.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"139_CR46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","volume":"5","author":"O Hermine","year":"2004","unstructured":"Hermine O, et al. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma. Hematol J. 2004;5(2):130\u20134.","journal-title":"Hematol J"},{"issue":"26","key":"139_CR47","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","volume":"113","author":"G Kchour","year":"2009","unstructured":"Kchour G, et al. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL). Blood. 2009;113(26):6528\u201332.","journal-title":"Blood"},{"issue":"13","key":"139_CR48","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","volume":"207","author":"H El Hajj","year":"2010","unstructured":"El Hajj H, et al. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med. 2010;207(13):2785\u201392.","journal-title":"J Exp Med"},{"key":"139_CR49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"\u2022 Ishida T, et al. Defucosylated anti-CCR4 monoclonal antibody(KW-0761) for relapsed adult T cell leukaemia -lymphhoma: a multicenter phase II study. J Clin Oncol. 2012;30:837\u201342. This paper decribes a phase II study of anti CCR4 antibody in relapsed ATLL patients reporting an overall response rate of 50\u00a0%.","journal-title":"J Clin Oncol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-012-0139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-012-0139-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-012-0139-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T01:44:40Z","timestamp":1594777480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-012-0139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,24]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1007\/s11899-012-0139-9","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,24]]}}}